– Additional monotherapy dose-escalation data from ongoing Phase 1/1b clinical trial of WTX-124 expected to be presented in the first…
CHARLESTOWN, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic…
Up to $3.5 M in cash proceedsUp to $4.5 M in debts conversion Proceeds to be used to further expand…
Solidifying Its Position as a Leading Medical Tourism Hub Newsweek World's Best Hospital 2024 (Malaysia) Newsweek World's Best Hospital 2024…
Mainz, Germany, March 7, 2024 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Sean…
Highlights: Immuron proceeding to Phase 3 registration strategy with the FDATravelan® topline clinical trial results demonstrate protective efficacy with single…
OGAP®-Verify allows for significantly enhanced sensitivity and specificity for improved target selection, dramatically accelerating drug target discoveryOGAP-Verify is now more…
Company is advancing mitochondriotropic therapeutic pipeline for rare neuromuscular disorders and neurodegenerative diseasesOXFORD, United Kingdom, March 07, 2024 (GLOBE NEWSWIRE)…
BEIJING, March 7, 2024 /PRNewswire/ -- A report from Science and Technology Daily: Sci-tech innovation has not only boosted the competitiveness…
Technology Platform Has Been Granted Patents in Over 40 Countries Including -- United States, Canada and EuropePatents Include United States…